PATENT CLAIM ANALYSIS

Application Number: 15751304
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "056000"]

Abstract:
The present invention relates to the development of a stomatological composition and a kit each comprising an NSAID such as ibuprofen, a heparin compound, or a pharmaceutically acceptable salt thereof for the prevention, alleviation, or treatment of inflammations associated with oral cavity diseases and/or pains/infections associated with the inflammations and of inflammatory pain diseases/infections of the pharynx and/or the esophagus, and to a method for producing the composition and a method of use of the composition for the production of a medicament.

Claim (Index 15):
The method according to  claim 14 , wherein the NSAID is at least one selected from the group consisting of ibuprofen, meloxicam, loxoprofen, celecoxib, and flurbiprofen, or the heparin compound is at least one selected from the group consisting of heparin, a heparinoid, and a low-molecular-weight heparin.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 88.0
- Lexical Diversity: 1.72549
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15181462', '15293535', '15795846', '13496818', '14797860']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7747318384540459
- 35 USC 102 Novelty (BERT): 0.49727579633232
- Combined Prediction Score: 0.7469862342418734
- Mean Citation Score: 189.816924
- Max Citation Score: 194.23996
- Similarity Product: 121.9522730124855

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test